|
1
|
Qu X, Zhai Y, Wei H, Zhang C, Xing G, Yu Y
and He F: Characterization and expression of three novel
differentiation-related genes belong to the human NDRG gene family.
Mol Cell Biochem. 229:35–44. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nichols NR, Agolley D, Zieba M and Bye N:
Glucocorticoid regulation of glial responses during hippocampal
neurodegeneration and regeneration. Brain Res Brain Res Rev.
48:287–301. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi SC, Kim KD, Kim JT, Kim JW, Yoon DY,
Choe YK, Chang YS, Paik SG and Lim JS: Expression and regulation of
NDRG2 (N-myc downstream regulated gene 2) during the
differentiation of dendritic cells. FEBS Lett. 553:413–418. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lusis EA, Watson MA, Chicoine MR, Lyman M,
Roerig P, Reifenberger G, Gutmann DH and Perry A: Integrative
genomic analysis identifies NDRG2 as a candidate tumor suppressor
gene frequently inactivated in clinically aggressive meningioma.
Cancer Res. 65:7121–7126. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Deng Y, Yao L, Chau L, Ng SS, Peng Y, Liu
X, Au WS, Wang J, Li F, Ji S, Han H, Nie X, Li Q, Kung HF, Leung SY
and Lin MC: N-Myc downstream-regulated gene 2 (NDRG2) inhibits
glioblastoma cell proliferation. Int J Cancer. 106:342–347. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim A, Yang Y, Lee MS, Yoo YD, Lee HG and
Lim JS: NDRG2 gene expression in B16F10 melanoma cells restrains
melanogenesis via inhibition of Mitf expression. Pigment Cell
Melanoma Res. 21:653–664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu XL, Liu XP, Lin SX, Deng YC, Liu N, Li
X and Yao LB: NDRG2 expression and mutation in human liver and
pancreatic cancers. World J Gastroenterol. 10:3518–3521.
2004.PubMed/NCBI
|
|
8
|
Kim YJ, Yoon SY, Kim JT, Song EY, Lee HG,
Son HJ, Kim SY, Cho D, Choi I, Kim JH and Kim JW: NDRG2 expression
decreases with tumor stages and regulates TCF/β-catenin signaling
in human colon carcinoma. Carcinogenesis. 30:598–605.
2009.PubMed/NCBI
|
|
9
|
Lee DC, Kang YK, Kim WH, Jang YJ, Kim DJ,
Park IY, Sohn BH, Sohn HA, Lee HG, Lim JS, Kim JW, Song EY, Kim DM,
Lee MN, Oh GT, Kim SJ, Park KC, Yoo HS, Choi JY and Yeom YI:
Functional and clinical evidence for NDRG2 as a candidate
suppressor of liver cancer metastasis. Cancer Res. 68:4210–4220.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim A, Kim MJ, Yang Y, Kim JW, Yeom YI and
Lim JS: Suppression of NF-κB activity by NDRG2 expression
attenuates the invasive potential of highly malignant tumor cells.
Carcinogenesis. 30:927–936. 2009.
|
|
11
|
Brabletz T, Jung A, Spaderna S, Hlubek F
and Kirchner T: Migrating cancer stem cells - an integrated concept
of malignant tumour progression. Nat Rev Cancer. 5:744–749. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Radisky DC: Epithelial-mesenchymal
transition. J Cell Sci. 118:4325–4326. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hirohashi S: Inactivation of the
E-cadherin-mediated cell adhesion system in human cancers. Am J
Pathol. 153:333–339. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yokoyama K, Kamata N, Hayashi E, Hoteiya
T, Ueda N, Fujimoto R and Nagayama M: Reverse correlation of
E-cadherin and snail expression in oral squamous cell carcinoma
cells in vitro. Oral Oncol. 37:65–71. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Poser I, Domínguez D, de Herreros A,
Varnai A, Buettner R and Bosserhoff A: Loss of E-cadherin
expression in melanoma cells involves up-regulation of the
transcriptional repressor Snail. J Biol Chem. 276:24661–24666.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Comijn J, Berx G, Vermassen P, Verschueren
K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D and van Roy
F: The two-handed E box binding zinc finger protein SIP1
downregulates E-cadherin and induces invasion. Mol Cell.
7:1267–1278. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thuault S, Valcourt U, Petersen M,
Manfioletti G, Heldin CH and Moustakas A: Transforming growth
factor-β employs HMGA2 to elicit epithelial-mesenchymal transition.
J Cell Biol. 174:175–183. 2006.
|
|
24
|
Gupta PB, Kuperwasser C, Brunet JP,
Ramaswamy S, Kuo WL, Gray JW, Naber SP and Weinberg RA: The
melanocyte differentiation program predisposes to metastasis after
neoplastic transformation. Nat Genet. 37:1047–1054. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hajra KM, Chen DY and Fearon ER: The SLUG
zinc-finger protein represses E-cadherin in breast cancer. Cancer
Res. 62:1613–1618. 2002.PubMed/NCBI
|
|
26
|
Lie-Venema H, Gittenberger-de Groot AC,
van Empel LJ, Boot MJ, Kerkdijk H, de Kant E and DeRuiter MC: Ets-1
and Ets-2 transcription factors are essential for normal coronary
and myocardial development in chicken embryos. Circ Res.
92:749–756. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Manoukian AS and Woodgett JR: Role of
glycogen synthase kinase-3 in cancer: regulation by Wnts and other
signaling pathways. Adv Cancer Res. 84:203–229. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hardt SE and Sadoshima J: Glycogen
synthase kinase-3β: a novel regulator of cardiac hypertrophy and
development. Circ Res. 90:1055–1063. 2002.
|
|
29
|
Zhou BP, Deng J, Xia W, Xu J, Li YM,
Gunduz M and Hung MC: Dual regulation of Snail by GSK-3β-mediated
phosphorylation in control of epithelial-mesenchymal transition.
Nat Cell Biol. 6:931–940. 2004.PubMed/NCBI
|
|
30
|
Bachelder RE, Yoon SO, Franci C, de
Herreros AG and Mercurio AM: Glycogen synthase kinase-3 is an
endogenous inhibitor of Snail transcription: implications for the
epithelial-mesenchymal transition. J Cell Biol. 168:29–33. 2005.
View Article : Google Scholar
|
|
31
|
Conacci-Sorrell M, Simcha I, Ben-Yedidia
T, Blechman J, Savagner P and Ben-Ze’ev A: Autoregulation of
E-cadherin expression by cadherin-cadherin interactions: the roles
of β-catenin signaling, Slug, and MAPK. J Cell Biol. 163:847–857.
2003.PubMed/NCBI
|
|
32
|
Kim YJ, Yoon SY, Kim JT, Choi SC, Lim JS,
Kim JH, Song EY, Lee HG, Choi I and Kim JW: NDRG2 suppresses cell
proliferation through down-regulation of AP-1 activity in human
colon carcinoma cells. Int J Cancer. 124:7–15. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park MY, Choi SC, Lee HS, Kim D, Baek KE,
Kim JT, Lim JS, Yeom YI, Chung JW, Kim JW, Myung PK, Lee HG, Kim JW
and Song EY: A quantitative analysis of N-myc downstream regulated
gene 2 (NDRG 2) in human tissues and cell lysates by reverse-phase
protein microarray. Clin Chim Acta. 387:84–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bussemakers MJ, Giroldi LA, van Bokhoven A
and Schalken JA: Transcriptional regulation of the human E-cadherin
gene in human prostate cancer cell lines: characterization of the
human E-cadherin gene promoter. Biochem Biophys Res Commun.
203:1284–1290. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chomczynski P and Sacchi N: Single-step
method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal Biochem.
162:156–159. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yook JI, Li XY, Ota I, Fearon ER and Weiss
SJ: Wnt-dependent regulation of the E-cadherin repressor snail. J
Biol Chem. 280:11740–11748. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Doble BW and Woodgett JR: Role of glycogen
synthase kinase-3 in cell fate and epithelial-mesenchymal
transitions. Cells Tissues Organs. 185:73–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou BP and Hung MC: Wnt, hedgehog and
snail: sister pathways that control by GSK-3beta and beta-Trcp in
the regulation of metastasis. Cell Cycle. 4:772–776. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ilyas M, Tomlinson IP, Rowan A, Pignatelli
M and Bodmer WF: β-catenin mutations in cell lines established from
human colorectal cancers. Proc Natl Acad Sci USA. 94:10330–10334.
1997.
|
|
40
|
Morin PJ, Sparks AB, Korinek V, Barker N,
Clevers H, Vogelstein B and Kinzler KW: Activation of β-catenin-Tcf
signaling in colon cancer by mutations in β-catenin or APC.
Science. 275:1787–1790. 1997.
|
|
41
|
Piepoli A, Cotugno R, Merla G, Gentile A,
Augello B, Quitadamo M, Merla A, Panza A, Carella M, Maglietta R,
D’Addabbo A, Ancona N, Fusilli S, Perri F and Andriulli A: Promoter
methylation correlates with reduced NDRG2 expression in
advanced colon tumour. BMC Med Genomics. 2:112009. View Article : Google Scholar
|
